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RESUMEN
Objetivos. Dada la relación existente entre periodontitis crónica y altos niveles de estrés oxidativo, esta 
revisión pretende clarificar qué papel puede desempeñar la ingesta de los diferentes antioxidantes de la 
dieta en el mantenimiento de un periodonto saludable y en la reducción del riesgo de padecer periodon-
titis crónica, así como el posible uso de terapias dietéticas basadas en estos para el tratamiento de dicha 
enfermedad.
Métodos. Se utilizó la base de datos de la National Library of Medicine, Washington, DC (MEDLINE: 
PubMed) y todos los estudios en animales y humanos tratando el tema de interés en escritos Inglés dis-
ponibles online desde la creación de la base de datos hasta Mayo de 2015 fueron recopilados.
Resultados. Los antioxidantes analizados a este respecto incluyen a la vitamina C, la vitamina A, algu-
nos carotenoides y polifenoles, y el coenzima Q; así como los minerales, hierro, cobre y zinc que forman 
parte de enzimas antioxidantes. Aun así hay una escasez generalizada de estudios con pocos estudios 
en humanos, la mayoría de tipo observacional. Entre los diferentes antioxidantes, la vitamina E y los po-
lifenoles parecen ser los que más evidencias a favor de su efecto beneficioso suman, pero en general los 
estudios son insuficientes para descartar o establecer qué antioxidantes son útiles y cuáles no.
Conclusiones. En general, los datos presentados indicarían que los antioxidantes de la dieta resultan be-
neficiosos para la salud periodontal, al menos bajo ciertas circunstancias. Sin embargo se necesitan más 
estudios para establecer la relación entre la periodontitis crónica y cada antioxidante concreto así como 
para diseñar intervenciones dietéticas útiles en la gestión de esta enfermedad.
Palabras clave: Gingivitis, Enfermedad periodontal, Micronutrientes, Fitoquímicos, Suplementos die-
téticos
ABSTRACT
Objectives. Given the relationship between chronic periodontitis and high levels of oxidative stress, this 
review aims to clarify what role can played the dietary intake of different antioxidants in maintaining a 
healthy periodontium and in reducing chronic periodontitis risk, as well as possible use of dietary thera-
pies based on them for this disease treatment.
Methods. The database of the National Library of Medicine, Washington, DC (MEDLINE PubMed) was 
used and all the studies in animals and humans are on the subject of interest in English writing online 
available from inception of the database until May 2015 were collected.
Results. Antioxidants analyzed in this regard include vitamin C, vitamin A, carotenoids and some poly-
phenols, and coenzyme Q; as well as minerals iron, copper and zinc that are constituents of antioxidant 
enzymes. Still, there is a paucity of studies with few human studies, mostly observational. Among the 
various antioxidants, vitamin E and polyphenols seem to have more evidence for its beneficial effect, but 
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in general the studies are insufficient to rule out or establish what 
antioxidants are useful and which are not.
Conclusions. Overall, the data presented indicate that dietary anti-
oxidants are beneficial for periodontal health, at least under certain 
circumstances. However more studies are needed to establish the 
relationship between chronic periodontitis and each specific anti-
oxidant and to design useful dietary interventions for this disease 
management.
Keywords: Gingivitis, Periodontal disease, Micronutrients, Phyto-
chemicals, Dietary supplements 
INTRODUCTION
Chronic periodontitis is a chronic disease associated to ag-
ing that represent the major cause of tooth loss in adults1 
and it may constitute a risk factor for other pathologies 
such as cardiovascular diseases2,3. It has been defined as an 
infectious disease resulting in inflammation within the sup-
porting structures of teeth and progressive attachment and 
bone loss4. As part of this process, prior to periodontitis, the 
first clinical manifestation to appear is gingivitis that has 
been defined as an inflammation of the gingiva in which 
the junctional epithelium remains attached to the tooth at 
its original level5. Overall, this disease begins as an initial 
response to bacterial infection is a local inflammatory reac-
tion that activates the innate immune system6,7. Amplifica-
tion of this initial localized response results in the release of 
an array of cytokines and other mediators and propagation 
of inflammation through the gingival tissues6,7. The failure 
to encapsulate this ‘‘inflammatory front’’ within gingival 
tissue results in expansion of the response adjacent to alve-
olar bone7. Lastly, the inflammatory process drives the de-
struction of connective tissue and alveolar bone that is the 
cardinal sign of periodontitis8. Along with bone loss, this 
disease is characterized by pocket formation and/or gin-
gival recession4. As the connective tissue attachment to the 
tooth breaks down, the junctional epithelium migrates in 
an apical direction and a periodontal pocket forms, which 
becomes lined by pocket epithelium with in-growth of rete 
pegs into the surrounding connective tissue9. 
In spite of the absence of studies quantifying reactive oxy-
gen species (ROS) directly due to the difficulties inherent in 
detecting them10, researches measuring the biomarkers gen-
erated by ROS reacting with different biomolecules have 
indicated a positive association between oxidative stress 
and periodontitis11-14. At the same time, less antioxidant sta-
tus has been noted15-16. Additionally, different studies have 
provided evidences for several mechanisms explaining 
how high oxidative stress levels could contribute to peri-
odontitis pathogenesis. On one hand, ROS at high levels, or 
chronically produced, can result in direct damage to cells 
and the extracellular matrix17-21. The accumulation of them 
could disrupt both, soft and calcified connective tissues of 
the peridontum (i.e. gums and alveolar bone). Degradation 
products found in studies analyzing gingival crevicular 
fluid22–26 and tissue extracts 21,27 from periodontitis patients 
are in consistency with this. However, it is important to 
note that the presence of collagen metabolites in gingival 
crevicular fluid could also be the result of a combination 
of proteolysis by host and bacterial collagenases at least in 
part, though oxidative damage may make a direct or indi-
rect contribution to their production10. On the other hand, 
products of this oxidative damage to matrix and serum 
protein can lead to further ROS-induced damage by their 
priming and chemotactic actions on neutrophils10 and al-
ter different fibroblasts functions28. According to that, it has 
been suggested that oxidation-dependent changes in colla-
gen within the periodontal connective tissues could retard 
neutrophil migration through the tissues and increase their 
potential to produce ROS 10. In addition, it has been report-
ed that certain ROS activate osteoclasts29 and promote os-
teoclast formation in vitro30. Lastly, some data also support 
that ROS directly can damage on tissue inhibitor of matrix 
metalloproteinases or induce alterations in matrix metallo-
proteinase expression 31–33 as occurs in other tissues34, 35–37.
As it is well known, humans and other organisms have 
effective defense systems to deal with continuous ROS 
to which they are exposed. Specialized defense factors to 
deal with the high oxidant challenge present in the differ-
ent organisms are referred to as antioxidants. Altogether, 
antioxidant system is complex and there are different types 
of antioxidants with different mechanism. Some antioxi-
dants prevent the generation of ROS, some are enzymes 
that destroy ROS, some are small water-soluble molecules 
that act as reducing agents to «neutralize» free radicals, and 
some absorb electrons or excess energy from ROS and «dis-
sipate» this within their complex lipophilic structure38,39. 
However, although our intrinsic antioxidant defense is 
highly effective, dietary input of antioxidants is needed40 
and some antioxidant present in food are essentials nutri-
ents. Still, conceptually at least, the other antioxidants that 
evolved to deal with oxidant challenge in plants could have 
a role to play in defending human tissues from this same 
challenge, augmenting our endogenous antioxidant sys-
tem in the prevention of oxidative stress40. Actually, pro-
tection by various antioxidants (or, better, diets containing 
antioxidants) against different chronic diseases and cancer 
has been attributed to their antioxidant capacity41. Low in-
takes of one or more of these antioxidant nutrients could 
reduce the body’s defenses against free radical damage and 
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increase susceptibility to health problems associated with 
free radical damage 42. This concept that enhanced optimal 
antioxidant defense of the body lowers risk of disease and 
slows biological aging40 would be apply to chronic peri-
odontitis. For this reason, the present review is aimed to 
clarify what role is played by different antioxidant dietary 
intake in promoting periodontal health and/or reducing 
the chronic periodontitis risk, as well as the possible use of 
dietary interventions based on for this disease treatment.
MATERIALS AND METHODS
For this review, a search was conducted in the electronic 
database of National Library of Medicine, Washington, DC 
(MEDLINE: PubMed) aimed to find both published studies 
in English language from inception of the database until 
May 2015. All relevant human and animal studies online 
available on the association of periodontitis or gingivitis 
and dietary antioxidant intake were included. For this, the 
following theme was introduced: (periodontitis OR gingi-
vitis) AND antioxidant AND (diet OR nutrition OR intake). 
However when they clearly assessed other forms periodon-
tal disease, as aggressive periodontitis, were excluded.
RESULTS
Ascorbic acid
L-ascorbic acid is also called vitamin C since is an essen-
tial nutrient for humans and other animals. As ascorbate, 
it is an enzymatic cofactor in a range of essential metabolic 
reactions in all animals and plants 43,44, but this vitamin is 
also known to act as antioxidant in living organisms 44. 
There are several reason making vitamin C an effective 
antioxidant: the low reduction potentials of ascorbate and 
ascorbyl radical (formed by one electron oxidation of ascor-
bate), the low reactivity of ascorbyl radical that readily dis-
mutates to ascorbate due to resonance stabilization of the 
unpaired electron, and the existence of multyple pathways 
to regenerate ascorbate from both the ascorbyl radical and 
dehydroascorbic acid. These last include enzyme-depend-
ent systems as the NADH-dependent semidehydroascor-
bate reductase and the NADPH-dependent selenoenzyme 
thioredoxin reductase; as well as enzyme-independent 
pathways including reduced gluthatione (GSH) and lipoic 
acid, thioredoxin reductase and the GSH-dependent en-
zyme glutaredoxin. On the other hand, ascorbic acid also 
behaves as a pro-oxidant since it has been shown to reduce 
transition metals such as cupric ions to cuprous and ferric 
ions to ferrous during conversion from ascorbate to dehy-
droxyascorbate in vitro. This reaction can generate super-
oxide and other reactive oxygen species. However, in the 
body, free transition elements are unlikely to be present 
while iron and copper are bound to diverse proteins 45.
Research into the relationship between vitamin C and 
periodontal alterations comes from as far as the eighteenth 
century when it was observed that scurvy was fully recov-
ered after a treatment with oranges and lemons 46 which 
are directly related to its role in collagen synthesis 44. More 
recently, different observational studies evaluating effects 
of dietary levels of this nutrient on a variety of outcomes 
related to periodontitis have been performed in humans, 
but findings reported by them have been different. Some 
observational studies have not found clear associations 
with periodontitis severity 47–49 or gingivitis presence 48,49. 
However, all are cross-sectional and in some cases intake 
estimates were obtained from a single 24-hour dietary re-
call 47. In contrast, other have displayed a negative associa-
tion between vitamin C intake and periodontitis support-
ing a positive role of vitamin C on periodontal health 50,51. 
Among them, there a cohort study indicating an inverse 
relationship between vitamin C intake and incidence rate 
ratio of disease progression from Niigata city (Japan), but 
it was performed in 75 years old persons 51. Supporting 
this finding, there is other cross-sectional study reported 
an inverse dose-dependent relationship between vitamin C 
intake and risk of periodontitis in a sample of 12,419 sub-
jects from NHANES III 50, a representative survey of the 
U.S. non-institutionalized population of adults aged 20-90 
years old. This relationship, although statistically signifi-
cant, was modest when the entire population was assessed. 
However, when smokers and non-smokers were evaluated, 
a slightly greater increased risk for periodontal disease was 
seen only in current and former tobacco users 50. 
Regarding experimental studies, animal research conduct-
ed in rats (Rattus norvergicus) fed on vitamin C-supple-
mented or -deficient diets by incorporated it to drinking 
water have shown positive effects for this nutrient 52,53. In 
one, periodontitis was experimentally induced by ligatures 
placement around molars for 4 weeks and dietary treat-
ment (1g/l vitamin C) started after removing ligatures. 
After 6 weeks, it was noted an improvement of reduced 
to oxidized glutathione ratio (GSH/GSSG) and a decrease 
in 8-hydroxy-2’ -deoxyguanosnie (8-OHdG) levels in gin-
gival tissue as well as plasma reactive oxygen metabolites 
levels which correlated to an increase in plasma vitamin C 
level indicating a oxidative stress decrease at both, system-
ic and local levels. Notwithstanding, the degrees of apical 
migration of the junctional epithelium and alveolar bone 
resorption remained unaffected by supplements, although 
the densities of polymorphonuclear leukocytes and active 
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(TRAP-positive) osteoclasts showed a 76 and 74% decrease, 
respectively 52. In contrast, similar vitamin C dosages have 
shown to prevented the effect of high-cholesterol diet for 12 
weeks on alveolar bone density and osteoclast differentia-
tion which correlated with decreased serum 8-OHdG ex-
pression 53. In spite of this last result in animals, none inter-
vention study in humans has reported clear positive effects 
for this nutrient. In 1965, a trial in children showed chewing 
on vitamin C-enriched tablets not improve effect on Rus-
sell’s peridontal index, an index of periodontitis severity, 
compared to mannitol-containing tablets that were used as 
placebo54. More recently, a cross-over trial have shown that 
chewing sugar free gum contained vitamin C for 3 months 
after scaling treatment to remove all supragingival and 
subgingival calculus reduces gingival bleeding but meas-
ures of pocket depth or attachment level were not taken, 
so treatment implications were not deeply known55. On the 
other hand, no effects also have been noted in other two 
investigations in patients that received root and planning 
therapy before a period of vitamin C supplementation 56,57.
Carotenoids and vitamin A
Carotenoids are a group of nearly 600 compounds lipid-sol-
uble plant pigments found naturally in many foods58. There 
are carotenoids either oxygenated or non-oxygenated hy-
drocarbons containing at least 40 carbons and an extensive 
conjugated double bond system and they can be found es-
terified to fatty acids or unesterified in plant tissues59. The 
predominant non-polar functional carotenoid are alpha-
carotene, beta-carotene, and lycopene are s and lutein is the 
primary polar functional carotenoid. From all carotenoids 
about 50 have provitamin A activity being beta-carotene the 
most important precursor. Antioxidant activity has been 
reported for vitamin A1 (retinol) and A2 (dehydroretinol) 
as well as for many pro-vitamin A compounds, including 
β- and α-carotenes. Moreover other carotenoids with little 
or no vitamin A activity, but that are found in substantial 
quantities in the human diet and in tissues, are also report-
ed to have antioxidant activity including lycopene, lutein, 
canthaxanthin, neoxanthin, violaxanthin, astaxanthin and 
zeaxanthin 60. The antioxidant activities of carotenoids and 
vitamin A are conferred by the hydrophobic chain of poly-
ene units that can quench singlet oxygen, neutralize thiyol 
radicals, and combine with and stabilize peroxyl radicals. 
In general, the longer the polyene chain, the greater the per-
oxyl radical stabilizing ability 61. Studies evaluating the role 
of this group of compounds on peridontitis from a dietary 
standpoint have been only observational, and results did 
not confirm its possible beneficial role. Furthermore, most 
of them only estimate vitamin A intake 47–49. In 1976, a cross-
sectional study in 56 patients from a dental clinic found a 
negative correlation between dietary vitamin A intake and 
Rusell’s periodontal index 47. Likewise, in the retrospective 
cohort study for two years in elderly Japanese mentioned 
above, it was noted a negative association between dietary 
beta-carotene intake and nº of teeth with periodontal dis-
ease progression, even after adjustment for several co-
founders, although α-carotene intake did not show associa-
tion62. Lastly, a survey that comparing female adolescents 
with and without gingivitis that assessed dietary vitamin 
A levels in the diet too, but no differences were observed 
49. Although there no measures to evaluate oxidative stress 
levels in these research, the fact of beta-carotene is the an 
efficient quencher of singlet oxygen 63 but vitamin A can-
not quench singlet oxygen and has a very small capacity to 
scavenge free radicals 64,65 this fact would be consistent with 
the possibility that this effect is due to its antioxidant activ-
ity. However, the paucity of studies does not allow to ob-
tain conclusions. Future efforts should be made to include 
some carotenoids in dietary assessments in this study type, 
specially in the case of and beta-carotene and lycopene that 
also has show an important antioxidant activity 66.
Tocopherols and tocotrienols
Tocopherols and tocotrienols are lipid-soluble food com-
ponents termed as «vitamin E» as a whole. This structure 
is featured by a phenolic-chromanol ring linked to an iso-
prenoid side chain that is either saturated (tocopherols) or 
unsaturated (tocotrienols). In addition, it possible to dis-
tinct four primary forms of tocopherols and tocotrienols, 
alpha, beta, gamma, and delta that differ in the number 
and position of methyl groups on the phenolic-chromanol 
ring rendering eight isomers of vitamin E 67,68. Vitamin E is a 
well-known antioxidant 69 that stops the production of ROS 
formed when fat undergoes oxidation 70. The antioxidant 
effects of vitamin E result from the incorporation of vitamin 
E into cellular membranes, where it inhibits peroxidation 
of lipids 71,72. There are data indicating dietary vitamin E 
beneficial role on periodontitis, although they only comes 
from cohort studies based on an elderly subset of Niigata 
city population 51,62. Meanwhile, research in rats using lig-
ature-induced periodontitis models have indicated that vi-
tamin E supplementation for 9 days reduce oxidative stress 
on gingivomucosal tissue, but this no implied necessary a 
decrease alveolar bone loss73. Still, there are other studies 
in rice rats (Oryzomus palustris) that naturally present peri-
odontitis74 where vitamin E supplements had a protective 
effect on bone loss in all cases75. Furthermore, a recent di-
etary intervention in humans following mechanical treat-
ment for chronic periodontitis have shown that adjunctive 
vitamin E supplementation improves periodontal healing 
as well as antioxidant defense represented by SOD activity 
both, in serum and saliva76. Therefore, the use of nutritional 
therapies based on vitamin E intake at least in combina-
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tion with other periodontal therapies seems promising but 
many researches on this topic is needed.
Iron, copper and Zinc
Several minerals have been taken account since they have 
been considered as antioxidants although really they are 
not, but they are essential for antioxidant enzyme activ-
ity77. Iron is a constituent of catalase, a hemeprotein, which 
catalyzes the decomposition of hydrogen peroxide. Copper 
form part of ceruloplasmin that fights against extracellu-
lar free radicals. Further, along with zinc, it forms part of 
superoxide dismutase (SOD)1 that is present in cell cyto-
sol participating in intracellular oxidative stress decrease. 
Likewise, zinc and manganese are the cofactors of the mi-
tochondrial enzyme, SOD2. Lastly, this group also includes 
selenium with is required for gluthatione peroxidase activ-
ity 42. Dietary intakes of iron, copper and zinc role on peri-
odontitis were assessed in the study performed on humans 
by Freeland et al.47, but associations with Russell’s perio-
dontal index were not found. Despite these data, associa-
tion presented in this paper can be influenced by several 
reasons since not fasting instruction was given to patients 
before blood samples collection. In addition to that, di-
etary data may be not representative because of a dietary 
recall of only 24 hours. Since them, new research on this 
topic have been performed only for zinc in both, humans78 
and animals79. Regarding first, a zinc-supplemented syrup 
was tested that seemed to exert some beneficial effects in 
a double-blind randomized study in children. In spite of 
periodontal index scores were similar at baseline, there 
were more children whose scores decreased in comparison 
to those where they increased, whereas those receiving pla-
cebo syrup showed similar proportions. In turn, gingival 
index decrease was occurred in more children in the two 
groups 78. In addition to this trial, research in rats also sup-
port the dietary zinc beneficial role in certain degree since 
zinc-deficient diets have been related to lower plaque and 
gingival indices scores, although probing depth remained 
unaffected 79. However, the effect of dietary content of the 
other two minerals on chronic periodontitis it has just been 
object of interest as well as the use of nutritional therapy 
with them. Therefore, there is insufficient evidence to avoid 
these three nutrients and other «antioxidant» minerals in 
future research. 
Polyphenols
Polyphenols are numerous and widely distributed mol-
ecules present in plants that contain one or more benzene 
rings and varying number of hydroxyl, carbonyl, and car-
boxylic acid groups. They commonly exist in conjugated 
forms with one or more attached sugar residues. The most 
common class of polyphenols is the flavonoids. Other types 
of polyphenols include catechins, thearubingens, theafla-
vins, isoflavones, and over 8000 others 67. The additon of 
several specific polyphenols to the diet have been tested in 
rodents models of periodontitis. In rat models of ligature-
induced periodontitis oral administration of resveratrol 
(trans-3,4ʹ,-5-trihydroxystilbene)80,81, mangiferin (C2-b-d-
glucopyranosyl-1,3,6,7-tetrahydroxyxanthone)82, baicalin 
(7-glucuronic acid, 5,6-dihydroxy-flavone)83, verbascoside 
(4,5-hydroxyphenylethanol bound to a b-(d)-glucopyrano-
side) and quercetin (3,5,7,3ʹ,4ʹ-pentahydroxyflavone)84 have 
shown to reduce alveolar bone loss, which in most of cases 
it was accompanied by of inflammation sings85,86. Similar 
effect on alveolar bone has been observed in a mouse peri-
odontitis model induced by A. actinomycetemcomitans infec-
tion for the compound84. Additionally, when it was meas-
ured, it was noted that this effect on bone loss correlates 
with reduced oxidative stress87 or levels of enzymes that 
promote it like iNOS83,87. In particular, quercetin has shown 
a clear antioxidant effect in the oral cavity against NO re-
sulting from nitrite reduction by certain oral bacteria which 
could extend to other compound of this type88. In rabbits, 
it has been reported a certain anti-inflammatory effect of 
supplementation with hydroxytyrosol. Specifically, it was 
reported that it reduced endothelial activation in rabbits 
that had developed atherosclerosis induced by a diet rich in 
saturated fats, but it did not improve endothelial activation 
and lower cellularity in gingival mucosa, which are also as-
sociated with this pathology89. However data about its ef-
fect on alveolar bone or periodontal oxidative stress levels 
was not be available. Hydroxytyrosol (3,4-dihydroxyphe-
nylethanol) is originated during the maturation of olives, 
storage of the oil and preparation of table olives by hydrol-
ysis of oleuropein90. In contrast with diet based on other fat 
sources (sunflower and fish oil), a virgin olive oil-based diet 
have shown to decrease alveolar bone breakdown associ-
ated with aging in rats that also displayed lower gingival 
lipid peroxidation 91. At present, it is well established that 
the health benefits of olive oil are not concentrated solely in 
its fatty acid content 92, so this effect could be attributed to 
its hydroxytyrosol content. 
Coenzyme Q
Coenzyme Q (CoQ) is a naturally occurring coenzyme 
formed from the conjugation of a benzoquinone ring with 
a hydrophobic isoprenoid chain of varying chain length, 
depending on the species93. It is found in every plant and 
animal cell and is located in the inner membrane system of 
the mitochondria, other membranes and in plasma lipopro-
teins94. Due to its ubiquitous presence in nature and its qui-
none structure, CoQ is also known as ubiquinone95. It exists 
in two molecular forms, ubiquinone, the oxidized form, 
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and ubiquinol, the reduced form, which are the basis for 
its antioxidant properties96. The well-recognized function 
of CoQ is mitochondrial energy coupling to produce ATP94. 
The other important function is that it acts as a primary 
scavenger of free radicals as it is well located in the mem-
branes in close proximity to the unsaturated lipid chains. 
Less well-established functions also include oxidation/re-
duction control of signal origin and transmission in cells, 
which induce gene expression, control of membrane chan-
nels, membrane stabilization and lipid solubility94. Clinical 
trials where CoQ was orally administrated to periodontitis 
patients have shown to increase the CoQ concentration in 
gums and suppresses gingival inflammation 97,98. The ben-
eficial role of dietary CoQ on this diseases is supported by a 
more recent research in rats maintained in different dietary 
treatments for 2 years91,99. In this, addition of low-dosages 
of CoQ to diet decreased alveolar bone loss associated with 
the consumption of a n-6 fatty acid-rich diet99. However, 
the only oxidative damage marker used, reactive substanc-
es (TBARS) levels, did not show significant differences, so 
it is not possible to clarify that this finding was due to a 
decrease in oxidative stress levels. Moreover, in this animal 
model gums usually showed no clear sings of inflamma-
tion91, so it is not possible to confirm its effect on gingival 
inflammation.
DISCUSSION
The proposal of this review was to clarify the role of the 
different antioxidant intake in promoting healthy aging of 
periodontium and/or reducing risk of chronic periodonti-
tis as well as the use of dietary treatment based on them 
in its treatment. After search and read carefully informa-
tion available on this topic, it has been noted a generalized 
paucity of studies, particularly in humans. Other added 
problem is that some of them not evaluate dietary intake 
effects on oxidative damage or antioxidant status and some 
antioxidants are essential nutrients that participate as co-
enzyme in other relevant process. Thus, in many cases, it is 
not possible to confirm that positive effects on periodontal 
tissues observed were due to their antioxidant activity. 
Among different dietary antioxidant, the most studied have 
been vitamin C followed by vitamin A and vitamin E. Con-
cerning vitamin C, the number of observational and ani-
mal studies suggesting clear positive effects on periodonti-
tis50,51,53 and reported an absence of statistical association or 
effect 47–49  have been similar. One reason explaining these 
differences could be that vitamin C intake only is relevant 
when subjects present some condition associated to high 
oxidative stress as smoking50 or even aging51. Likewise, vi-
tamin A intake role on periodontal health remain unclear. 
On the other hand, results from studies focused on vitamin 
E effect have been mostly positive 51,62,74,76. Similarly, benefi-
cial effect has been also reported for different polyphenols 
80–84,87, as well as CoQ 99 but they only have been tested in 
animals, although for many their in vivo antioxidant effects 
seems due to iNOS expression or activity modulation and 
not to free radical scavenging. Unfortunately, at the mo-
ment, experimental interventions in humans have been 
reduced to vitamin C54–57 but also for E 76 or Zinc78, where 
vitamin E have result the most interesting although it were 
used after mechanical treatment. 
CONCLUSIONS
In general, there are a paucity of studies on possible rela-
tionship between dietary antioxidants and periodontitis, 
particularly in humans, and they are very different. In ad-
dition many of them are observational studies that do not 
deepen on possible mechanisms under associations report-
ed. Still, data presented here, altogether, would indicate 
that dietary intake of antioxidant is beneficial for periodon-
tal health, at least under some circumstances. However, 
more studies are needed in order to establish the relation-
ship between chronic periodontitis and each antioxidant as 
well as to design useful dietary interventions to manage 
this disease.
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